LFCR
Lifecore Biomedical·NASDAQ
--
--(--)
--
--(--)
3.83 / 10
Netural
Liquidity flow evaluation: 7.65/10 demonstrating robust fund flow characteristics. Optimistic overall, block, and Extra-large patterns are mitigated by pessimistic Small, Medium, and Large indicators, pointing to positive flow perspective. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 1 analyst assessments, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-04
InstitutionKeybanc
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of LFCR?
- LFCR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.83/10 (Netural).
